{"organizations": [], "uuid": "85c0a20d462082890250085e79fc5f9b0cf52435", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180112.html", "section_title": "Archive News &amp; Video for Friday, 12 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shanghai-shyndec-pharmaceutical-un/brief-shanghai-shyndec-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1P73O4", "country": "US", "domain_rank": 408, "title": "BRIEF-Shanghai Shyndec Pharmaceutical unit receives GMP certificate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.749, "site_type": "news", "published": "2018-01-12T18:26:00.000+02:00", "replies_count": 0, "uuid": "85c0a20d462082890250085e79fc5f9b0cf52435"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shanghai-shyndec-pharmaceutical-un/brief-shanghai-shyndec-pharmaceutical-unit-receives-gmp-certificate-idUSL4N1P73O4", "ord_in_thread": 0, "title": "BRIEF-Shanghai Shyndec Pharmaceutical unit receives GMP certificate", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "shanghai shyndec pharmaceutical co ltd", "sentiment": "negative"}, {"name": "gmp", "sentiment": "negative"}, {"name": "brief-shanghai shyndec pharmaceutical", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "guangdong food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 12 (Reuters) - Shanghai Shyndec Pharmaceutical Co Ltd\n* Says Shantou-based pharmaceutical unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration and the valid period is until Jan. 3, 2023\n* Certificate issued to unitâ€™s products including troche, hard capsule and granula\nSource text in Chinese: goo.gl/zfLxSe\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/zfLxSe", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-12T18:26:00.000+02:00", "crawled": "2018-01-13T14:46:19.002+02:00", "highlightTitle": ""}